Valuation Photocure ASA OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 11:08:47 2026-07-02 EDT			5-day change	1st Jan Change
6.010 ^USD	-2.75%		0.00%	-14.14%

07-16	Linc increased net asset value by 6 percent in the second quarter	FW
06-30	Photocure ASA Announces CFO Transition	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,769	2,895	1,827	1,681	1,900	1,514	-	-
Change	-	4.55%	-36.89%	-8.01%	13.04%	-20.31%	-	-
Enterprise Value (EV) ¹	2,483	2,639	1,567	1,387	1,661	1,311	1,293	1,260
Change	-	6.28%	-40.61%	-11.53%	19.77%	-21.05%	-1.42%	-2.55%
P/E	-89.3x	-40.2x	6,740x	-344x	-1,190x	16.8x	35.3x	36x
PBR	-	-	-	-	-	5.29x	4.69x	4.5x
PEG	-	-0x	-67x	0x	17.9x	-0x	-0.7x	-17.43x
Capitalization / Revenue	7.68x	7.73x	4.09x	3.42x	3.57x	2.29x	2.28x	2.12x
EV / Revenue	6.89x	7.05x	3.51x	2.82x	3.12x	1.99x	1.94x	1.76x
EV / EBITDA	136x	-107x	28.2x	28.2x	57.8x	7.67x	13.3x	11.5x
EV / EBIT	-426x	-53.9x	56.4x	68x	-2,229x	8.14x	16.1x	13.5x
EV / FCF	113x	-469x	35.4x	18.4x	95x	13x	19.9x	34x
FCF Yield	0.89%	-0.21%	2.82%	5.43%	1.05%	7.66%	5.03%	2.94%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.15	-2.66	0.01	-0.18	-0.06	3.393	1.613	1.58
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	360.5	374.5	446.2	491.7	532.6	659.7	664.7	713.7
EBITDA ¹	18.3	-24.63	55.49	49.19	28.73	171	97.33	109.3
EBIT ¹	-5.826	-49	27.81	20.4	-0.745	161	80.33	93
Net income ¹	-30.9	-71.86	0.267	-4.81	-1.519	91.33	43.33	54.33
Net Debt ¹	-285.4	-255.6	-259.5	-293.9	-238.9	-202.7	-221.3	-254.3
Reference price ²	102.70	106.80	67.40	62.00	71.40	56.90	56.90	56.90
Nbr of stocks (in thousands)	26,960	27,106	27,106	27,106	26,607	26,607	-	-
Announcement Date	2/23/22	2/23/23	2/21/24	2/19/25	2/18/26	-	-	-

¹NOK in Million²NOK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.93x	12.68x	26.75x	0.57%	1,067B
JOHNSON & JOHNSON	28.24x	6.45x	17.87x	2.04%	635B
ABBVIE INC.	32.64x	7.65x	15.73x	2.65%	458B
ROCHE HOLDING AG	19.22x	4.69x	11.59x	2.82%	347B
NOVARTIS AG	21.56x	5.71x	14.24x	2.81%	295B
ASTRAZENECA PLC	21.1x	4.45x	12.31x	1.98%	262B
NOVO NORDISK A/S	14.14x	5.26x	10.84x	3.54%	216B
AMGEN INC.	24.66x	6.48x	11.43x	2.68%	203B
GILEAD SCIENCES, INC.	-46.58x	5.59x	30.88x	2.55%	161B
Average	16.77x	6.55x	16.85x	2.4%	404.83B
Weighted average by Cap.	24.80x	7.95x	18.71x	1.96%